# FDA Inspection 1176478 - Fisiopharma Srl - June 21, 2022

Source: https://www.keypedia.com/records/fda_inspections/fisiopharma-srl/7d264e91-21f8-4771-b553-505921c8e142
Source feed: FDA_Inspections

> FDA Inspection 1176478 for Fisiopharma Srl on June 21, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1176478
- Company Name: Fisiopharma Srl
- Inspection Date: 2022-06-21
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1107133 - 2019-09-27](https://www.keypedia.com/records/fda_inspections/fisiopharma-srl/eaeb6742-08ae-454e-8002-d15ee6fb026f)
- [FDA Inspection 988928 - 2016-09-26](https://www.keypedia.com/records/fda_inspections/fisiopharma-srl/e8836f25-a113-4f18-adec-01538ef3240e)

Company: https://www.keypedia.com/companies/fisiopharma-srl/51c980e4-3287-4bc8-a51d-4fe2c414329c

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c